- Subject Introduction
Department of Hematology
The Department of Hematology was founded in 1985 and is one of the key disciplines of the hospital. The first chief of the department was Dr. Zhu Zhou and the present chief is Dr. Chun Wang, who is also the chairman of the Shanghai Society of Hematology from 2014-2016. Over the past decades, the department has developed into one of the largest centers of hematology in Shanghai with more than 80 beds, which include 10 laminal air flow rooms for hematopoietic stem cell transplants (HSCT). Over 800 cases of HSCT had been performed for the treatment of hematological disorders and solid tumors in the center since 1992. Currently, the department has 23 physicians.10 excellent young physicians in the department were sent abroad in the past several years, such as the United States, Japan, Germany and Australia for further training in basic research and clinical practice.
In recent years, a comprehensive treatment system has been established for autologous HSCT, allogeneic HLA matched related and unrelated HSCT, umbilical cord blood HSCT and haplo-identical HSCT. As one designated hematopoietic stem cell harvesting hospital of China Marrow Donor Program, more than 200 healthy donors had successfully donated their peripheral blood stem cell in the center. The department takes the leading position in both the transplant case number and the long term outcomes in Shanghai.
In addition, as a teaching hospital of Medical School of Shanghai Jiao Tong University and Nanjing Medical College, there are teaching programs for undergraduates and graduates. More than 20 students received postgraduate training in the department, including 9 students for doctor degree and 13 for master degree. Eight national and municipal research programs had been completed and 43 articles had been published in peer-reviewed journals in the past 5 years. In 2008, due to the achievements in research on donor chimerism and hematopoietic reconstitution after allogeneic stem cell transplant, the department won the third prize of “Shanghai Medical Science and Technology Awards”. In 2016, the transplant team won the second prize of “Scientific and Technological Advancement Award of Ministry of Education” for achievements in salvage treatment of refractory and relapsed hematological malignancies with allogeneic HSCT.
At present, the director of the department is Dr. Chun Wang, the vice director is Dr. Ying Tong, the executive director of the south branch is Dr. Xianmin Song, the vice executive director of the south branch is Dr. Liping Wan.